Skip to main content
. 2015 Sep 14;93(11):775–784. doi: 10.2471/BLT.14.146274

Fig. 2.

Patients with a negative Mycobacterium tuberculosis test, China, 2011–2012

CrI: credible interval.

Notes: The sample includes all 139 enrollees of rifampicin-resistant or multidrug-resistant tuberculosis who were enrolled in the comprehensive programme and remained on treatment six months after initiating treatment. The CrIs reflect sampling uncertainty as well as uncertainty relating to missing data.

Fig. 2